Skip to main content

Calling All Innovators

Your inventive idea could help the growing number of patients who rely on plasma-derived immunoglobulin.

Story
Gloved hands of a CSL Behring researcher in the lab

Global biotechnology leader CSL Behring and Australia’s deep tech incubator Cicada Innovations are launching an innovation challenge for scientists, researchers and rare disease patients. The mission: to brainstorm new ways to help meet growing worldwide demand for plasma-derived immunoglobulin.

Plasma is a natural, but limited, resource needed to make life-saving medicines for people who are living with rare diseases such as primary immunodeficiency. Organizers are casting a wide net, and also looking outside the plasma industry, to uncover fresh approaches to boost supply. Awards will include mentorship from a CSL Behring leader as well as a monetary prize.  

Learn more about the challenge by attending the official kickoff.

When: 14 April in Asia Pacific /April 13 in North America and Europe

Where: Virtual – register here

Who: Open call to all innovators

Participants have until May 26 to submit their ideas.